Basic Information
| LncRNA/CircRNA Name | ANRASSF1 |
| Synonyms | RASSF1-AS1, ANRASSF1 |
| Region | GRCh38_3:50337511-50338300 |
| Ensemble | ENSG00000281358 |
| Refseq | NR_109831 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | RNA-seq, qPCR, RNAi, Western blot, RIP, ChIP, Cell proliferation assay etc. |
| Sample | cell lines (HeLa, MDA-MB-231, LNCaP and MCF-9) |
| Expression Pattern | differential expression |
| Function Description | Overexpression of ANRASSF1 increases the cell proliferation rate and decreases cell death. |
| Pubmed ID | 23990798 |
| Year | 2013 |
| Title | The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. |
External Links
| Links for ANRASSF1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |